An injectable alpha-emitting radiopharmaceutical to treat patients with bone metastasis from castration-resistant prostate cancer.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An injectable alpha-emitting radiopharmaceutical to treat patients with bone metastasis from castration-resistant prostate cancer.
If you have a Hayes login, click here to view the full report on the Knowledge Center.